Health Screening in the UK: Complete Guide (2026)

The UK has some of the best screening programmes in the world — but they only cover a handful of conditions. If you rely solely on the NHS for health screening, significant gaps remain: no routine prostate cancer screening, no liver or kidney function testing for healthy adults, no structural imaging, no hormonal assessment, and no genetic risk profiling. This guide maps out everything available for health screening in the UK in 2026 — NHS and private — so you can build a complete picture.

What Is Health Screening?

Screening tests for disease in people who feel well and have no symptoms. The goal is catching problems early — when treatment is simpler, cheaper, and far more likely to succeed. Screening is different from diagnostic testing (which investigates symptoms you already have).

The numbers make the case: bowel cancer caught at stage 1 has a 90%+ five-year survival rate; at stage 4, it drops below 10% (Cancer Research UK, 2023). Most cancers, cardiovascular disease, diabetes, liver disease, and kidney disease are all more treatable when detected early.

NHS Screening Programmes (2026)

These are free, evidence-based, and automatically offered to eligible residents. Do not skip them.

Cancer screening

Bowel cancer screening

• Test: Faecal Immunochemical Test (FIT) — a simple home test kit posted to you
• Who: Everyone aged 50-74 (progressively rolling out from the previous 60-74 range)
• Frequency: Every 2 years
• What it does: Detects hidden blood in stool — an early indicator of bowel cancer or pre-cancerous polyps
• If positive: Referral for colonoscopy (roughly 1 in 50 FIT results trigger further investigation)
• Effectiveness: Estimated to reduce bowel cancer deaths by ~25% in screened populations (Cochrane review)

Breast cancer screening

• Test: Mammography (low-dose X-ray of the breasts)
• Who: Women aged 50-70 (some areas piloting 47-73 as part of the AgeX trial extension)
• Frequency: Every 3 years
• What it does: Detects breast lumps and calcifications too small to feel — before symptoms develop
• High-risk women: Those with BRCA1/2 mutations or strong family history may be offered annual MRI + mammography from age 30 through the NHS high-risk programme

Cervical screening

• Test: HPV (human papillomavirus) testing, with cytology if HPV-positive
• Who: Women and people with a cervix aged 25-64
• Frequency: Every 3 years (ages 25-49), every 5 years (ages 50-64)
• What it does: Detects high-risk HPV strains and abnormal cervical cells before they become cancerous
• Effectiveness: Cervical screening prevents roughly 70% of cervical cancer deaths (NHS Digital)

Cardiovascular screening

NHS Health Check

• Who: Adults aged 40-74 without existing cardiovascular conditions, diabetes, or kidney disease
• Frequency: Every 5 years
• Tests: Blood pressure, total cholesterol (often just total and HDL, not a full lipid panel), BMI, waist measurement, HbA1c or fasting glucose
• Limitations: Only every 5 years. Does not include advanced cardiovascular markers (ApoB, Lp(a), hs-CRP, homocysteine), hormones, organ function panels, imaging, or genetic testing. It's a starting point, not a thorough assessment.

Abdominal aortic aneurysm (AAA) screening

• Test: Abdominal ultrasound (quick and painless)
• Who: Men aged 65 (one-off invitation). Women are not offered AAA screening despite also being at risk.
• What it does: Detects dangerous swelling of the main abdominal blood vessel. Ruptured AAA is fatal in roughly 80% of cases — screening and surveillance saves lives.

Other NHS screening

• Diabetic eye screening — Annual retinal photography for everyone with diagnosed diabetes. Detects diabetic retinopathy before vision loss occurs.
• Antenatal screening — Blood tests, ultrasounds, and assessments during pregnancy (Down syndrome, Edwards syndrome, Patau syndrome, sickle cell, thalassaemia, neural tube defects)
• Newborn screening — Blood spot test (PKU, cystic fibrosis, sickle cell, congenital hypothyroidism, and 5 other conditions), hearing test, physical examination

What the NHS Does Not Screen For

Significant gaps exist in NHS screening. This isn't a criticism — the NHS prioritises population-level programmes with strong evidence. But it means that many common and detectable conditions go unscreened unless you arrange it yourself.

Condition / Area	NHS Coverage	The Gap
Prostate cancer	No formal programme. PSA available on request from GP but not proactively offered.	The UK has no structured prostate cancer screening — despite prostate cancer being the most common cancer in men (52,000+ new cases/year)
Lung cancer	Targeted pilot programmes (Lung Health Checks) in some areas for high-risk groups	No national lung cancer screening programme yet, despite lung cancer being the biggest cancer killer
Liver disease	None	Non-alcoholic fatty liver disease (NAFLD/MASLD) affects 25-30% of UK adults. No screening exists despite rising prevalence.
Kidney function	Tested only in people with diabetes, hypertension, or known kidney disease	No screening for the general population. Early kidney disease is reversible; advanced kidney disease isn't.
Thyroid function	Not routinely tested	Thyroid dysfunction affects roughly 2% of the UK population (up to 5% of women over 60). Often misdiagnosed as depression, fatigue, or ageing.
Vitamin and mineral status	Not routinely tested	Vitamin D deficiency or insufficiency in ~40% of UK adults (PHE). B12 deficiency common in vegans, older adults, and those on metformin/PPIs.
Hormones	Not routinely tested	Perimenopause, menopause, and testosterone decline are assessed only when patients present with symptoms — not proactively.
Full body imaging	Not available	No structural imaging screening for asymptomatic adults. MRI can detect tumours, aneurysms, organ abnormalities, and spinal conditions before symptoms appear.
Genetic cancer risk	Limited — mainly offered after a cancer diagnosis or with strong family history meeting specific criteria	Preventive genetic testing (BRCA, Lynch syndrome) is not widely available through the NHS for people without a personal cancer history
Biological age	Not available	No epigenetic testing available on the NHS

Private Screening: Filling the Gaps

Blood tests

Private blood tests cover far more than the NHS Health Check. A thorough panel includes:

• Advanced cardiovascular markers — Full lipid profile (LDL, HDL, triglycerides, non-HDL), ApoB (particle count — better predictor of cardiovascular risk than LDL alone), Lp(a) (genetically determined, test once), hs-CRP (cardiovascular inflammation), homocysteine
• Metabolic health — HbA1c, fasting glucose, fasting insulin (detects insulin resistance years before blood sugar rises)
• Organ function — Full liver panel (ALT, AST, GGT, ALP, albumin, bilirubin), kidney panel (creatinine, eGFR, urea, uric acid), thyroid (TSH, free T4, free T3)
• Full blood count — Screens for anaemia, infection, blood cell disorders
• Vitamins and minerals — Vitamin D, B12, folate, iron studies (ferritin, serum iron, transferrin saturation), magnesium
• Hormones — Testosterone (men), oestradiol/progesterone/FSH (women), DHEA-S, cortisol
• Cancer markers — PSA (men 45+), CA125 (women with risk factors)

MRI scanning

Private MRI adds structural information that blood tests can't provide:

• Full body MRI (from £1,399) — Screens brain, spine, chest, abdomen, pelvis, and bones in one 60-90 minute session. The most thorough single screening investigation available.
• Brain MRI (from £275) — Screens for aneurysms, tumours, white matter disease, structural anomalies.
• Cardiac MRI (from £349) — The reference standard for heart structure and function. Particularly valuable with family history of heart disease or for endurance athletes.
• Targeted scans — Specific body areas from £249. No referral needed, appointments typically within 1-5 working days.

DNA testing

Genetic testing identifies inherited risk factors — test once, results are permanent:

• Cancer predisposition — BRCA1/2 (breast and ovarian cancer), Lynch syndrome genes (colorectal, endometrial), CHEK2, ATM, PALB2
• Cardiovascular genetics — Familial hypercholesterolaemia (affects ~1 in 250 people, most undiagnosed)
• Pharmacogenomics — How you metabolise common medications (statins, antidepressants, blood thinners)
• Nutritional genetics — Lactose intolerance, coeliac disease predisposition, caffeine metabolism

Epigenetic testing

TruAge biological age testing measures your body's biological age through DNA methylation markers. Unlike genetic testing (which shows what you're born with), epigenetic testing shows the cumulative effect of your lifestyle — diet, exercise, sleep, stress, alcohol, smoking. It's a single metric that tracks whether your health interventions are actually working.

Recommended Screening by Decade

20s-30s

• NHS cervical screening (women, from 25)
• Baseline blood panel every 1-2 years — establish your personal normal ranges while young and healthy
• STI screening if relevant
• Skin mole check if fair-skinned, history of sunburn, or family history of melanoma
• DNA test if family history of cancer, heart disease, or other hereditary conditions
• Eye test every 2 years from late 20s

40s

• NHS Health Check at 40 (free — take it)
• Annual blood panel including advanced cardiovascular markers, organ function, hormones, and vitamins
• Baseline full body MRI — establish a structural baseline, then repeat every 2-3 years
• PSA baseline (men) — establish your personal level for future comparison
• TruAge epigenetic test — baseline biological age measurement
• DNA test if not already done
• Eye test every 2 years (glaucoma risk increases from 40)
• Dental check every 6-12 months
• Skin mole check annually

50s

• NHS bowel cancer screening (FIT test, every 2 years)
• NHS breast screening (women, every 3 years)
• Continued NHS cervical screening
• Annual blood panel
• Full body MRI every 2-3 years
• Prostate MRI if PSA rising or elevated (men). Prostate MRI from £349.
• Cardiac MRI or CT calcium score — especially with cardiovascular risk factors
• TruAge annually
• Bone density consideration (women approaching or in menopause)

60s and beyond

• All of the above, plus:
• NHS AAA screening (men at 65)
• More frequent cardiovascular monitoring
• Annual MRI screening for those with risk factors or known findings being monitored
• Cognitive assessment if memory concerns arise. Brain MRI from £275.
• Bone density monitoring
• Annual eye test (macular degeneration, diabetic retinopathy, glaucoma all become more common)

How Much Does Private Screening Cost?

Test	Cost	Frequency	Annual Cost (Amortised)
Blood panel	£100-£300	Annually	£100-£300
Full body MRI	From £1,399	Every 2-3 years	£470-£700
DNA test	£100-£300	Once	One-off
TruAge	~£250	Annually	~£250

Starting budget: Annual blood tests (£200-300/year) are the most cost-effective screening tool. Add MRI when your budget allows. Do a DNA test when you're ready. You don't have to do everything at once.

Full programme: £800-£1,200 per year covers annual blood tests, MRI every 2-3 years (amortised), and annual TruAge. For comparison, the average UK household spends roughly £1,200/year on takeaway food (ONS, 2024).

For more on building a personalised screening plan, see our annual health MOT guide and health scans in your 40s.

Frequently Asked Questions

Is NHS screening enough?

It's a good starting point but covers a narrow range. NHS screening addresses bowel, breast, and cervical cancer plus basic cardiovascular risk — but only at wide intervals (every 2-5 years). It doesn't cover prostate cancer, liver disease, kidney function, thyroid, hormones, vitamins, structural imaging, or genetic risk. Private screening fills those gaps.

What age should I start private screening?

Blood tests are worthwhile from your late 20s to establish personal baselines. MRI screening becomes most relevant from your 40s, when cancer and cardiovascular disease risk begins to increase meaningfully. Genetic testing can be done at any age, particularly if you have a family history of hereditary conditions.

Can I use private results on the NHS?

Yes. Share your private reports with your NHS GP, who can add them to your medical record, arrange specialist referrals, and order further investigations — all at no additional cost to you.

Is health screening actually worth it?

The evidence for established screening programmes (bowel, breast, cervical) is strong — they save lives. The evidence for broader private screening (full body MRI, comprehensive blood panels) is less established at a population level, but the logic is straightforward: detecting conditions when they're treatable is better than detecting them when they're not. The question is not whether early detection is valuable — it is — but whether the cost and any psychological impact of incidental findings are acceptable to you.